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Dad1 has been shown to play a role in preventing apoptotic cell death and in regulating levels of N-linked glycosylation in
Saccharomyces cerevisiae and the BHK hamster cell line. To address the in vivo role of Dad1 in these processes during
ulticellular development, we have analyzed mice carrying a null allele for Dad1. Embryos homozygous for this mutation
express abnormal N-glycosylated proteins and are developmentally delayed by embryonic day 7.5. Such mutants exhibit
aberrant morphology, impaired mesodermal development, and increased levels of apoptosis in specific tissues. These defects
culminate in homozygous embryos failing to turn the posterior axis and subsequent lethality by embryonic day 10.5. Thus,
Dad1 is required for proper processing of N-linked glycoproteins and for certain cell survival in the mouse.
© 2000 Academic Press
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Glycosylation is an important modification of pro-
teins expressed on the cell surface or secreted into
the extracellular space. Interfering with proper glycosyl-
ation can affect protein surface expression, stability, or
interactions with other proteins. Changes in glycosyla-
tion have been described during mouse development
(Muramatsu, 1994), as well as during processes such as
inflammation and oncogenesis (Hakomori, 1996), and yet
it is unclear how the regulation of glycosylation is
accomplished.
In the yeast Saccharomyces cerevisiae, the oligosac-
charyltransferase (OST) complex that catalyzes the first
step of N-linked glycosylation consists of at least six
1 Present address: Hooper Foundation, UCSF, San Francisco, CA
94143.
2 To whom correspondence should be addressed at the Division
f Immunology and Cancer Research Laboratory, Department of
olecular and Cell Biology, University of California at Berkeley,
erkeley, California 94720-3200. Fax: (510) 642-0468. E-mail:
inoto@uclink4.berkeley.edu.
76subunits. The smallest subunit is the protein OST2, which
has significant sequence homology (40%) to the hamster
protein Dad1 (Defender against apoptotic death) (Silberstein
et al., 1995). The Dad1 gene was cloned via complementa-
tion of a temperature-sensitive mutant of the hamster cell
line BHK21 that undergoes apoptotic cell death at the
restrictive temperature (Nakashima et al., 1993). Both yeast
and hamster Dad1 proteins are required for normal levels of
N-linked glycosylation (Makishima et al., 1997; Silberstein
et al., 1995), and Dad1 can be biochemically isolated with
the OST complex from human and canine cells (Kelleher
and Gilmore, 1997). Because some fraction of proteins
appears to be fully glycosylated in the absence of yeast or
hamster Dad1, Dad1 is probably not an essential catalytic
subunit of the OST complex and may instead have a
regulatory function.
Both yeast and BHK21 cells require Dad1 for cell viability
(Nakashima et al., 1993; Silberstein et al., 1995). It is
possible that yeast and BHK21 cells both depend on the
proper expression of at least one N-glycoprotein for sur-
vival, while differentiated cells within a multicellular or-
ganism may not all be as dependent on Dad1 for viability.
0012-1606/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
u
t
(
i
g
1
3
d
l
a
a
v
m
f
77Dad1-Deficient Mice Express Abnormal GlycoproteinsWe have analyzed mouse embryos homozygous for a null
allele of the Dad1 gene. Such embryos express altered
N-glycosylated proteins, fail to develop beyond the turning
stage of midgestation, and show an increased frequency of
localized apoptosis.
MATERIALS AND METHODS
PCR
Genomic DNA was purified from embryos as previously de-
scribed (Patapoutian et al., 1995). The primer sequences recogniz-
ing the Dad1 genomic locus are as follows (see Fig. 1A for details):
primer a, gat gga agg att tgg gac atg ac; primer b, cgg aca aaa cat gaa
gga ac; primer c, ctt tgc ctc ctg aga gcc; primer d, gcg cat cgc ctt cta
tcg. PCR was performed at 94°C for 1 min, 58°C for 1 min, and
72°C for 1 min for 30 cycles. RT-PCR was performed as described
previously except without radioactive nucleotides (Hong et al.,
1999).
Extracts
All protein extracts were prepared by lysing cell suspensions or
embryos in lysis buffer (3% SDS, 10 mM b-mercaptoethanol, 6.25
mM Tris–HCl, pH 6.8, 20% glycerol) on ice for 1 h with occasional
vortexing. Membranes were pelleted by spinning samples in a
microfuge for 10 min at 4°C. Supernatants were boiled prior to
loading on SDS–glycine polyacrylamide gels.
Glycosylation
Tunicamycin (1.2 mM final concentration) was added to over-
night cultures of confluent NIH3T3 cells. Purified laminin was
treated overnight with N-glycosidase F, and 100 ng was used for
SDS–PAGE analysis. All reagents were purchased from Boehringer
Mannheim.
Western Analysis
Anti-Dad1 antibodies were raised in rabbits as described previ-
ously (Nakashima et al., 1993). Resulting antiserum was purified
over a column coupled with antigenic peptide. Western blots were
blocked overnight at 4°C in 10 mM Tris–HCl, pH 7.5, 100 mM
NaCl (TN)/5% milk/0.1% Tween 20 and probed in the same
solution with a 1:1000 dilution of antiserum. Secondary antibody
was anti-rabbit HRP (Clontech) detected with ECL (Amersham),
with washes of TN/0.1% Tween 20 after antibody incubation. For
Westerns, anti-laminin g1 antibody (Dr. R. Brandenberger) was
tilized in an identical fashion, except Tween 20 was omitted from
he overnight blocking solution. Anti-a-fetoprotein antibody (ICN
Biomedical/Cappel) was used at a dilution of 1:2000.
Mice
The generation of ND26 mice has been described previously
Hong et al., 1997). Embryos for analysis were obtained from
ntercrosses of [129/SvJ 3 C57BL/6] F1 or F2 animals heterozygous
for the Dad1 mutation. Noon of the day of the plug is considered
embryonic day 0.5 (E0.5). For each time point, at least three litters
were examined. Decidua were fixed in 4% paraformaldehyde
Copyright © 2000 by Academic Press. All rightovernight at 4°C and transferred to PBS. Embryos were embedded
in plastic or paraffin blocks and sectioned at 5 mm. Polysaccharide
staining using periodic acid–Schiff (PAS) reagent (Sigma) was coun-
terstained with hematoxylin. For laminin staining of embryo
sections, JB-4 plastic sections (Polysciences, Inc.) were treated with
0.25% trypsin for 30 min at 37°C, washed in 0.2% Tween 20/PBS,
blocked in 5% sheep serum, and exposed to anti-laminin (Collabo-
rative Research) at 1:100 in 0.1% BSA/PBS overnight at 4°C. After
washes, sections were treated with 0.3% hydrogen peroxide for 15
min and then washed and blocked again. Signal was amplified with
biotinylated anti-rabbit IgG (Sigma) and streptavidin/peroxidase
(Vector Laboratories) and then treated with the peroxidase sub-
strate True Blue (Kirkegaard and Perry Laboratories). Apoptosis
staining was performed with TUNEL kit (Oncor).
RESULTS
ND26 Homozygosity Leads to Absence
of Dad1 and Lethality
We have previously described a targeted deletion of
regulatory sequences downstream of the T cell receptor a
gene (Hong et al., 1997). This mutant allele, referred to as
ND26, also replaces the noncoding third exon of the Dad1
ene with the neomycin resistance selection marker (Fig.
A). The removal of these regulatory sequences and/or the
9 untranslated region of the Dad1 gene results in a lack of
etectable Dad1 transcripts from the targeted allele in
heterozygous mice (Hong et al., 1997). Such heterozygous
mice were intercrossed, and embryos were genotyped with
primers designed against the third exon of Dad1 (designated
a and b in Fig. 1A) and with primers specific to the mutant
allele (c and d). One-quarter of embryos displayed abnormal
development (see below) and typed as homozygous mu-
tants; such mutants were not recoverable for analysis after
E10.5 (data not shown). An example of such typing is
shown, in which abnormal E8.5 embryos were homozygous
for the ND26 allele, while normal embryos were genotyped
as either wildtype or heterozygous (Fig. 1B). Using RT-PCR
on wild-type embryos, we determined that Dad1 RNA is
present as early as E6.5 and is in both embryonic and
extraembryonic tissues at E7.5 (Fig. 1C).
We also generated purified antibodies against mouse
Dad1 protein for use in immunoblotting to establish that
the ND26 mutation results in a true null allele (Fig. 1D,
eft). Indeed, abnormal E9.5 embryos did not express detect-
ble amounts of Dad1 protein (lane 4). This antibody was
lso used to assess Dad1 protein levels in extracts from
arious adult tissues (Fig. 1D, right). As seen for adult
ouse RNA (Hong et al., 1997), Dad1 protein levels varied
rom tissue to tissue, but were detectable in all samples.
Dad1 Homozygous Mutants Are Impaired
in Protein Glycosylation
Dad1 can be isolated as a subunit of the oligosaccharyl-
transferase enzyme in yeast, canine, and BHK cells (Kelle-
her and Gilmore, 1997; Silberstein et al., 1995). In yeast and
s of reproduction in any form reserved.
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Copyright © 2000 by Academic Press. All rightBHK cells lacking Dad1, immunoblotting of glycoproteins
has indicated partial defects in N-glycosylation, such that a
given glycoprotein will contain species that are fully glyco-
sylated to nonglycosylated (Makishima et al., 1997; Silber-
stein et al., 1995). We have taken a similar approach to
investigate levels of N-linked glycosylation in mouse Dad1
mutants by analyzing embryonically expressed N-linked
glycosylated proteins by Western blotting. Laminin is a
major glycoprotein component of basement membranes
FIG. 2. Analysis of N-glycoproteins in Dad1 mutants. (A) Protein
extracts were resolved via 6% SDS–PAGE and probed with anti-
laminin g1 antibody. These four blots represent separate gels, and
herefore the migration of laminin is not directly comparable
etween blots (see text). Left: Extracts from NIH3T3 cells cultured
n the absence (2) or presence of tunicamycin (1TM) and purified
aminin g1 treated in vitro with (1GF) or without (2) N-glycosidase
F are altered in apparent molecular weight. Right: Protein from an
entire mutant (M) compared with aliquot of a normal E9.5 embryo
(N) also shows altered migration, but the mutant laminin has a
higher molecular weight than fully deglycosylated laminin (1TM).
(B) E9.5 extracts from normal (N) or mutant (M) embryos probed
with anti-a-fetoprotein antibody.
was diluted 10-fold for the GAPDH reactions. (D) Immunoblotting
with anti-Dad1 antibody. (Left) ND26 mutants do not express Dad1
protein. Embryos isolated at E9.5 were lysed in detergent buffer and
loaded onto a 15% polyacrylamide gel, transferred to nitrocellu-
lose, and probed with purified anti-Dad1 peptide antibody followed
by anti-rabbit secondary. Normal embryos were pooled and lysed
together in 30 ml per embryo, and 3, 2, or 1 ml (lanes 1, 2, and 3,
respectively) was loaded into each well. Mutants were lysed
individually, and the entire extract was loaded (lane 4). While Dad1
is detectable in normal embryos, mutants lack Dad1 protein. By
Ponceau S staining, a single mutant had total protein content
equivalent at least to that of lane 2 (data not shown). (Right)
Expression of Dad1 protein in adult mouse tissues (s, spleen; lu,
lung; l, liver; k, kidney; h, heart). 20 mg of cell extracts were run onFIG. 1. Identification of homozygous ND26 embryos null for
Dad1. (A) Diagram of the wild-type and mutated (ND26) Dad1
genomic loci. The exons of Dad1 are shown in black, while those
of the T cell receptor a constant region are shown in gray. A
diamond indicates the T cell receptor a transcriptional enhancer,
nd EcoRI sites are marked (E). Barbs with lowercase letters
epresent PCR primers. (B) PCR typing of E8.5 embryos from
eterozygous intercrosses. Primers a and b recognize sequences in
he third exon of Dad1 and are thus specific to the wild-type Dad1
llele. Primer d recognizes sequences in the neomycin resistance
arker and is thus mutant allele-specific when used with primer c,
hich recognizes Dad1 intronic sequences. The negative control
CR containing no genomic DNA is indicated by H2O. (C) RT-PCR
on RNA from wild-type E6.5 and E7.5 embryos, including embryos
dissected into embryo proper only (emb) and extraembryonic only
(extra). Increasing cycles of PCR were used to demonstrate unsat-15% SDS–polyacrylamide gel.
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Copyright © 2000 by Academic Press. All rightand is highly expressed in developing embryos (Leivo et al.,
1980). A shift in the migration of laminin g1 was detectable
via SDS–PAGE when protein extracts of NIH3T3 cells
grown in the presence of the N-glycosylation inhibitor
tunicamycin (Fig. 2A, 1TM) or when purified laminin g1
as treated in vitro with N-glycosidase F (Fig. 2A, 1GF).
aminin g1 from mutant E9.5 embryo extracts also mi-
rated at a lower apparent molecular weight (MW) than
ild-type or heterozygous E9.5 embryonic laminin g1 (Fig.
2A, right). Compared to either laminin g1 in the presence of
unicamycin or N-glycosidase F, the mutant laminin g1 ran
at a higher apparent MW (Fig. 2A, right), indicating that
major laminin g1 fraction expressed in the absence of Dad1
till retains some N-linked glycosylation but less than
ild-type embryonic laminin g1. This difference in appar-
ent MW is not due to developmental retardation of the
mutant embryos since laminin g1 from normal embryos
isolated between E8.0 and E9.5 migrated at the same
apparent MW as fully glycosylated laminin (data not
shown). By using a second isoform-specific anti-laminin
antibody, we saw that laminin b was similarly affected in
ad1 homozygous mutants (data not shown).
The serum glycoprotein a-fetoprotein (AFP) is highly
xpressed in the embryonic yolk sac and fetal liver (Chen et
l., 1997). To determine the extent of AFP glycosylation, we
lso analyzed AFP migration by Western blot. Extracts from
9.5 Dad1 mutant embryos contained AFP that migrated at
lower apparent MW than AFP from wild-type extracts
Fig. 2B), suggesting that Dad1 is required for normal levels
f N-linked glycosylation of multiple embryonically ex-
ressed proteins.
Development of ND26 Homozygous Embryos
Whole-mount analysis of E8.5 embryos revealed a gross
developmental defect in Dad1 mutant embryos: PCR-typed
homozygous mutants lagged in their rate of development a
day behind heterozygous or wild-type littermates (Figs.
3A–3C). By E9.5, while normal littermates had turned and
proceeded well into organogenesis (Fig. 3D, left), homozy-
gous mutants could be found at an earlier stage of develop-
ment with discernable headfolds, a beating heart, and
somites but a relatively shortened, underdeveloped poste-
proper is shown at the bottom of the section, while the extraem-
bryonic structures and ectoplacental cone (epc) are at the top.
Mesoderm formation is impaired in many mutants (arrow). (D–F) H
and E stain of E8.5 normal (D) and mutant (E and F) littermates.
Sections are shown at the same magnification; note the overall size
difference which is apparent at this time point. The headfolds (hf)
and neural tube (nt) of the wild-type embryo are discernible in this
section, while the mutants’ embryo proper (ep) and chorion (ch) are
labeled. The advanced mutant (E) also possesses a heart (h), somites
(s), and headfolds. Breaks in visceral endoderm (arrow) were oftenFIG. 3. Delayed development in the absence of Dad1. (A–C)
Whole-mount normal (A) and homozygous mutant (B and C)
littermates isolated at E8.5. The yolk sac (ys) is partially removed
from the normal embryo. In the homozygous mutants, the embryo
proper is apparent at the bottom. (D) Side view of whole-mount
E9.5 embryos. The normal embryo (left) has a completely fused
neural tube while the Dad1 mutant littermate (right) still exhibits
an unturned axis and a relatively undersized posterior region.
Headfolds (hf) and heart (h) of the mutant are indicated. We have
not observed a mutant embryo develop beyond this stage.
FIG. 4. Analysis of embryonic structures at E7.5 and E8.5. (A–C)
Hematoxylin and eosin (H and E) staining of parasagittal sections ofobserved in mutants at this stage.
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80 Hong et al.rior axis (Fig. 3D, right). These homozygous mutant em-
bryos were always unturned and sometimes had the hydro-
ponic allantois that afflicts many mutant strains unable to
form a proper chorioallantoic connection (data not shown).
At E10.5, mutants were essentially identical to E9.5 mu-
tants, but had begun to deteriorate (data not shown).
Analysis of sectioned embryos at E7.5 and E8.5 uncovered
more specific defects in embryonic development (Fig. 4).
Within the E7.5 embryo proper (Figs. 4A–4C), epiblast
cavity formation was defective. In extreme cases (Fig. 4C),
all three germ layers appeared reduced in amount relative to
normal littermates, with mesoderm formation being par-
ticularly affected. Not only were there fewer mesodermal
cells relative to the embryo size, but the cells appeared
more closely packed (Fig. 4C, arrow). By E8.5 (Figs. 4D–4F),
some abnormal embryos showed better epiblast cavity
expansion and formed mesodermal derivatives such as
heart and somites but still lagged behind normal litter-
mates, being one-half in size (Fig. 4E). On the mixed
129/SvJ 3 C57BL/6 strain background, there was some
ariability in degree of phenotype as we could sometimes
nd more severely affected E8.5 embryos at a developmen-
al stage prior to organogenesis and further reduced in size
Fig. 4F). Analysis of E6.5 litters did not reveal obvious
efects in Dad1 mutant embryos (data not shown).
Interestingly, extraembryonic structures of Dad1 mutant
mbryos were often not delayed to the same extent as the
mbryo proper. The ectoplacental cones of abnormal em-
ryos were also usually normal in size relative to the
mbryonic site and seemed to differentiate to produce
ascular connections with the maternal circulation. Never-
heless, the exocoelomic cavity often did not appear well
ormed in mutants, and the decidual cavities were typically
arrower in shape than those of normal littermates, perhaps
ontributing to the contorted appearance of the embryos at
7.5. E8.5 mutants (Figs. 4E and 4F) also exhibited abnormal
ecidual cavity dimensions, being on average about 70%
he length and only 40% the width of normal littermates
data not shown). Furthermore, mutants often suffered from
iscontinuities in the visceral endoderm layer at this time
oint (Fig. 4E, arrow, and see below).
Extraembryonic Defects in Dad1 Mutant Embryos
We looked closer at such extraembryonic defects in the
abnormal embryos. We examined the Reichert’s membrane,
which largely consists of glycosylated proteins such as
laminin (Leivo et al., 1980). When the Reichert’s membrane
as examined by either PAS staining (Figs. 5A and 5B) or
nti-laminin staining (Figs. 5C and 5D), we observed a
hickening of this layer in the abnormal embryos. This
hickening was associated with two abnormalities seen in
he closely juxtaposed parietal endoderm cells: their attach-
ent to the Reichert’s membrane was defective in Dad1
utants, and the nuclei of these cells stained much darker
ith hematoxylin (Fig. 5B) although they did not appear to
e apoptotic (see below).
Copyright © 2000 by Academic Press. All rightA second major extraembryonic structure, the visceral
ndodermal layer surrounding the developing embryo, se-
retes important serum factors, many of which are glyco-
roteins such as AFP. We observed that a number of abnor-
al embryos contained breaks in the visceral endoderm,
ypically at the point where it meets the chorion in normal
mbryos (Figs. 5E and 5F). The visceral endoderm layer was
sually also thicker in Dad1 mutants, with enlarged apical
acuoles frequently present (arrowheads). Together these
efects in the extraembryonic membranes of Dad1 mutants
ay impair their normal supportive function and thereby
ontribute to the poor development of the embryo proper.
Apoptosis in Dad1-Null Embryos
The gene for Dad1 was cloned by complementation of a
cell line that undergoes apoptosis in the absence of Dad1
protein (Nakashima et al., 1993). We therefore asked
whether the lack of Dad1 results in excess apoptosis in
mouse embryos. Hematoxylin and eosin staining frequently
showed pyknotic nuclei in sections of mutant E7.5 embryos
(Figs. 6A–6C), both in embryonic mesoderm and in ecto-
derm, indicating that more cell death occurs in the absence
of Dad1. We asked whether this cell death was indeed
due to apoptosis by utilizing terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL). By
this method, we also observed an increased frequency of
localized cell death in sections of mutant embryos. Normal
embryos contained few TUNEL1 cells at E7.5 (Figs. 6D and
6G), the most prominent staining seen in decidual tissue
being eroded as the embryo grows. Mutant E8.5 embryos
(Figs. 6E and 6H), which are at a stage of development
similar to that of E7.5 wild-type embryos, exhibited excess
apoptosis in the embryo proper, primarily at the distal tip.
At E9.5, mutant embryos exhibited large regions of cells in
both ectodermal and mesodermal tissues that were
TUNEL1 (Figs. 6F and 6I). As described above, mutant
embryos were still recoverable at E10.5, so apoptosis of
embryonic tissue preceded the process of resorption. Impor-
tantly, this abundant apoptosis was prominent only in the
embryo proper and not typically in the extraembryonic
tissues; for instance, parietal endoderm cells were not
TUNEL1. Therefore, the lack of Dad1 appears to trigger an
poptotic pathway in specific areas of mouse embryos.
DISCUSSION
In recent years, there has been a growing appreciation
that varied forms of protein regulation impinge upon sig-
naling pathways important for development. For instance,
cholesterol modification (Porter et al., 1996) and ubiquiti-
nation (Harbers et al., 1996) have recently been shown to be
important for specific developmental pathways through
their effects on known or unknown proteins. Glycosylation
is another protein modification that can influence expres-
sion and function of important signaling molecules and
s of reproduction in any form reserved.
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81Dad1-Deficient Mice Express Abnormal Glycoproteinstherefore affect development. Changes in levels of glycosyl-
ation during development have been reported (Muramatsu,
1994), but the mechanisms responsible for regulating such
changes remain unclear. We describe a null mutation of
Dad1 that appears to decrease levels of N-linked glycosyl-
ation, leading to an increase in apoptosis and disruption of
normal mouse development.
Dad1 and Glycosylation
Dad1 was first isolated in a screen for genes involved in
growth regulation (Nakashima et al., 1993). Its homology to
yeast Ost2p and its presence in preparations of oligosac-
charyltransferase from human and dog cells (Kelleher and
Gilmore, 1997) have prompted investigation of its role in
N-linked glycosylation. The OST enzyme complex cata-
lyzes transfer of the sugar from the dolichol donor to the
target nascent proteins in the endoplasmic reticulum and
hence is one of the earliest enzymes in the pathway of
N-linked glycosylation. As such, any loss-of-function phe-
notype would likely affect most, if not all, N-glycoproteins,
and regulation of Dad1 levels may be a means of regulating
global glycosylation levels.
In this work we present evidence that Dad1 is required for
OST function in mice. In our analysis of laminin g1, a
highly glycosylated protein, mouse Dad1 mutants express
an intermediate-sized population of laminin proteins. We
observe that a-fetoprotein is undersized and therefore also
likely underglycosylated in mutant embryos. Our Western
results indicate a partial defect that would probably con-
found efforts to look directly at gross carbohydrate levels on
unpurified glycoproteins. Our suggestion that the Dad1
mouse mutants still retain some level of N-linked glyco-
sylation agrees with reports that Dad1 proteins from other
species are not essential catalytic subunits of OST, but
perhaps regulatory subunits or partially redundant sub-
units. In yeast ost2 mutants, carboxypeptidase Y was
shown to lack N-glycosylation at some of the normally
glycosylated asparagines, resulting in multiple bands when
analyzed by electrophoresis (Silberstein et al., 1995). In
hamster mutant cells, a transfected reporter glycoprotein
containing two potential sites was shown to be roughly
50% nonglycosylated in the restrictive Dad1-null state
(Makishima et al., 1997). These data are consistent with the
idea that Dad1 is absolutely required to ensure that all
potentially glycosylated sites are in fact glycosylated. Our
results therefore shed light on the mechanisms involved in
determining in vivo levels of glycosylation.
Despite the partial nature of this glycosylation defect,
embryos lacking Dad1 are unable to develop normally. Such
mutants are indistinguishable from wild-type embryos be-
fore E7.5 (data not shown) and are able to proceed until the
turning stage of early organogenesis, albeit at a delayed rate
relative to normal littermates and with specific defects in
both embryonic and extraembryonic tissues. As predicted
by this phenotype, Dad1 RNA is found in E6.5 embryos as
well as in both embryonic and extraembryonic tissues at
Copyright © 2000 by Academic Press. All right7.5. In comparison, the N-linked glycosylation inhibitor
unicamycin arrests cultured mouse embryos at the blasto-
yst stage (Surani, 1979). Therefore, in the complete ab-
ence of N-glycosylation, in vitro-cultured embryos are able
o develop to the blastocyst stage, but an unknown process
fter blastocyst formation requires N-glycosylation. Pre-
umably, Dad1 mutants must retain enough N-linked gly-
osylation to complete this particular process before their
ventual arrest. In the analysis of another N-glycosylation
nzyme, homozygous mutants lacking the MGAT1 gene
xhibit impaired complex modification of the termini of
-linked sugars, presumably resulting in more mild, spe-
ific changes in the glycosylation of various target proteins
han those of Dad1 mutants. It is therefore not surprising
hat the MGAT1-null strain develops approximately 1 day
eyond Dad1-null embryos, until just past the turning stage,
ut with multiple defects including abnormal neural tissue
orphogenesis (Ioffe and Stanley, 1994; Metzler et al., 1994).
Extraembryonic Membrane Function
Because the interference with normal glycosylation un-
doubtedly affects the expression and/or function of mul-
tiple proteins, it has been a challenge to determine which
impaired glycoproteins contribute to the phenotypes ob-
served in glycosylation mutants. Clues may lie in the
precise description of such phenotypes, since these details
may point to which molecules may be affected. For in-
stance, a significant portion of the defects we observe in
Dad1 mutants overlaps with those reported in mutants
with abnormalities in visceral endoderm function. Dad1
mutants have thickened Reichert’s membrane, poor pari-
etal endoderm cell attachment, and delayed development of
the embryo proper accompanied by localized apoptosis, all
of which can result from visceral endoderm impairment as
seen in HNF-4, GATA-6, and huntingtin gene-targeted
mutants (Chen et al., 1994; Duncan et al., 1997; Dragatsis
et al., 1998; Koutsourakis et al., 1999; Morrisey et al., 1998;
Zeitlin et al., 1995). The role of the visceral endoderm in
secreting vital glycosylated growth factors could explain
why a glycosylation mutant would partially phenocopy
visceral endoderm mutants. In addition, Dad1-null mutants
often contain breaks and irregular vacuoles in the visceral
endoderm, further suggesting that this structure is impaired
in the absence of Dad1. The altered laminin staining we
have seen in Reichert’s membrane of Dad1 mutants could
further signify impairment of signals from the extraembry-
onic tissues to the embryo proper. Interestingly, melanoma
and PC12 cell spreading depends on the carbohydrate moi-
eties of laminin in vitro (Dean et al., 1990), raising the
possibility that the poor parietal endoderm attachment
could result from incomplete glycosylation of laminin and
other glycoproteins in the Reichert’s membrane. Clearly
additional studies are needed to dissect which glycoproteins
are primarily responsible for the Dad1-null phenotype, but
our current analysis suggests that extraembryonically ex-
pressed glycoproteins are strong candidates.
s of reproduction in any form reserved.
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83Dad1-Deficient Mice Express Abnormal GlycoproteinsApoptosis and Dad1
Our analysis of mouse embryos deficient in Dad1 expres-
sion shows that the lack of Dad1 results in apoptosis in
some tissues. The distal tip of the primitive streak embryo
seems particularly prone to apoptosis in the absence of
Dad1. It is possible that the apoptosis we observe is not a
cell-autonomous effect since supportive structures are de-
fective in Dad1-null embryos. As mentioned above, the
distal tip of the embryo undergoes apoptosis in response to
visceral endoderm defects in various mutant embryos. It is
possible to study the requirement for Dad1 in embryonic
versus extraembryonic tissues by creating tetraploid aggre-
gates with wild-type cells (Guillemot et al., 1994; Hakem et
al., 1996). If the apoptosis we observe is a cell-autonomous
defect, it would suggest that these dying cells are particu-
larly sensitive to Dad1 levels. Perhaps this specific cell
death reflects the differing needs of various cell types for
proteins that depend on N-linked glycosylation for proper
expression and function. For instance, it has been hypoth-
esized that cells lacking attachment to basement mem-
brane can be triggered to undergo apoptosis to create cavi-
ties during normal development (Coucouvanis and Martin,
1995). The glycosylation defect in Dad1 mutants may lead
to an excess of cells losing such attachment and therefore
initiation of an apoptotic program.
To summarize, we present evidence that the targeted
inactivation of Dad1 results in a partial glycosylation defect
and describe multiple morphological anomalies in gastru-
lation stage embryos lacking Dad1, including irregular
epiblast shape, poor mesoderm development, and abnormal
extraembryonic membranes. We hypothesize that one of
the specific pathways impaired in Dad1-null mutants in-
volves the signals mediated by glycosylated proteins from
the visceral endoderm to the embryo proper that promote
its growth and gastrulation. Dad1-null embryos also show
poor decidual cavity formation and increased apoptosis,
additional processes that are also likely sensitive to changes
in levels of glycosylation on key molecules.
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